Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A)

NACompletedINTERVENTIONAL
Enrollment

326

Participants

Timeline

Start Date

June 27, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

January 30, 2019

Conditions
Tinnitus
Interventions
DEVICE

PS1

Participants in this arm shall be given an audio stimulus which comprises of a sequence of tones, mixed with a broadband noise that is spectrally modified to compensate for any hearing loss. Electrical pulses in the somatosensory stimulation are synchronous with the tones.

DEVICE

PS2

Participants in this arm shall be given an audio stimulus which comprises of a sequence of tones, mixed with a broadband noise that is spectrally modified to compensate for any hearing loss. Electrical pulses in the somatosensory stimulation are uncorrelated and asynchronous with the tones.

DEVICE

PS3

Participants in this arm shall be given an audio stimulus which comprises of a sequence of single-frequency tones mixed with a broadband noise with the frequency characteristics of both chosen outside the region of any hearing loss. Electrical pulses in the somatosensory stimulation are uncorrelated and asynchronous with the tones.

Trial Locations (2)

Unknown

University Hospital Regensburg, Regensburg

St. James's Wellness Trust Clinical Research Facility, Dublin

Sponsors
All Listed Sponsors
collaborator

University Hospital Regensburg

OTHER

lead

Neuromod Devices Ltd.

INDUSTRY

NCT02669069 - Treatment Evaluation of Neuromodulation for Tinnitus (TENT-A) | Biotech Hunter | Biotech Hunter